SEPTInvestingStart Free

PCRX 8-K: Acquisition

Pacira BioSciences

Filed with the SEC on · accession 0001628280-26-071129

PCRX filed a 8-K (current report) with the SEC on Nov 5, 2026. Pacira BioSciences disclosed that Viatris commenced a tender offer to acquire all outstanding shares for $36.50 per share in cash, with a subsequent merger to make Pacira a wholly owned subsidiary of Viatris.

Summary of the filing

Pacira BioSciences disclosed that Viatris commenced a tender offer to acquire all outstanding shares for $36.50 per share in cash, with a subsequent merger to make Pacira a wholly owned subsidiary of Viatris. Pacira will not issue Q3 2026 earnings and is withdrawing its 2026 financial guidance during the pendency of the transaction.

For details, click here →How to read a 8-K →

Key details

Cash offer price per share$37
TargetPacira BioSciences, Inc.
AcquirerViatris Inc.
Acquirer subsidiaryPeach Purchaser Sub Inc.

✦ Ask GOAX AI about this filing — what it means for PCRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PCRX?

Click here

Frequently asked questions

What did PCRX file with the SEC on Nov 5, 2026?

PCRX filed a 8-K (Acquisition). Pacira BioSciences disclosed that Viatris commenced a tender offer to acquire all outstanding shares for $36.50 per share in cash, with a subsequent merger to make Pacira a wholly owned subsidiary of Viatris. Pacira will not issue Q3 2026 earnings and is withdrawing its 2026 financial guidance during the pendency of the transaction.

What does a acquisition mean for PCRX stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other PCRX SEC filings

Get alerts when PCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PCRX overviewPCRX analysisPCRX newsLatest SEC filings